
BC Cancer estimates the average-risk patient’s lifetime risk of pancreas ductal adenocarcinoma at 1.3%. In contrast, pancreatic neuroendocrine tumors (NETs) are rare. The pancreatic NET incidence was... Read More

BC Cancer estimates the average-risk patient’s lifetime risk of pancreas ductal adenocarcinoma at 1.3%. In contrast, pancreatic neuroendocrine tumors (NETs) are rare. The pancreatic NET incidence was... Read More

Pancreatic cystic lesions are being increasingly encountered in clinical practice due to the increased use of cross-sectional imaging.[1] Incidental pancreatic cysts are identified in up to 20% of... Read More

Key points Assessment and management of individuals at risk for pancreatic cancer: Assess family history. Modify risk factors. Discuss the benefits, harms, and limitations of screening... Read More

Clinical pearls: What to know about hepatitis B care Chronic hepatitis B virus (HBV) infection is often asymptomatic until advanced liver disease develops. All adults aged 18 years or older... Read More

Cataracts are the progressive opacification of the transparent native crystalline lens. This eventually results in a decline in visual function for the patient and an obstructed view of the fundus... Read More